Addressing the problem while tissue retains regenerative capacity offers better outcomes than waiting until degeneration becomes established
Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages
Although the absolute risk of clinically recorded alopecia associated with GLP-1 receptor agonist use is low, the observed association may still influence patients satisfaction, adherence, and decisions to start or continue therapy, Yong Chen, PhD, of the University of Pennsylvanias Perelman School of Medicine, wrote
Step 4: Monitor Progress and Adjust Dosage if Needed Tracking your progress regularly is key to making sure the treatment is working effectively
And it minimizes the risk of severe nausea or vomiting that could lead to early discontinuation
People start eating less, sometimes a lot less